Preoperative prediction and localization of synchronous metastases in colon cancer: the role of CECT combined with clinical characteristics

结肠癌同步转移的术前预测和定位:增强CT结合临床特征的作用

阅读:2

Abstract

OBJECTIVES: This study aimed to assess the utility of preoperative contrast-enhanced computed tomography (CECT) and clinical characteristics in predicting the presence and location of synchronous metastases in colon cancer (CC) patients. METHODS: A retrospective analysis was conducted on pathologically confirmed CC patients who underwent CECT within two weeks prior to radical resection and lymphadenectomy. Synchronous metastases were confirmed via biopsy or characteristic imaging findings. Two independent radiologists reviewed CECT features, including enhancement patterns, tumor characteristics, and lymph node status. Both univariate and multivariate logistic regression analyses were employed to evaluate the distribution of CECT features. RESULTS: The final cohort included 212 patients (95 males and 117 females, with a mean age of 64 years). Distant metastases were categorized as synchronous liver metastasis (65 patients), synchronous peritoneal metastasis (19 patients), and metastases to other sites (22 patients). Elevated carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels, increased tumor length, higher tumor length-to-thickness ratio, presence of tumor necrosis, lymph node necrosis, and arterial-venous phase CT value differences emerged as independent predictors of synchronous metastases in CC. A predictive model, incorporating these parameters, exhibited strong predictive capability (the area under the curve (AUC) = 0.852, sensitivity: 0.802; specificity: 0.736, accuracy: 0.769). Additionally, tumor necrosis and ascites were significantly associated with synchronous peritoneal metastases, with the model demonstrating high predictive efficacy (AUC = 0.869, sensitivity: 0.895; specificity: 0.782, accuracy:0.802). CONCLUSIONS: Integrating clinical characteristics with CECT imaging features provides an effective means of predicting synchronous distant metastases and their locations in CC patients, aiding in the development of personalized treatment plans that may enhance patient survival and quality of life.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。